INSTIL BIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.72 USD | -0.92% |
|
+0.09% | +40.68% |
| 26/04 | Instil Bio, Inc. Announces Board Changes | CI |
| 15/04 | North American Morning Briefing : Stock Futures -2- | DJ |
Chart calendar Instil Bio, Inc.
04cc4eafa04b.qxRyJpPkkMo9U9yhkUkhbn9WDuCvl3wlSrafijzaweA.3TkkVvGx-b0JC76UoytXJCVmb5jAxAVtHILn-1DtqqLfcABt6pLYuXUMmQ~c6e7eb0d81ae0ea59b664ddcb158207d
Upcoming events on Instil Bio, Inc.
Past events on Instil Bio, Inc.
| 22/03/2024 02:30 am | Q4 2023 Earnings Release |
| 14/06/2023 | Annual General Meeting |
| 11/05/2023 04:32 pm | Q1 2023 Earnings Release |
| 31/03/2023 04:30 pm | Q4 2022 Earnings Release |
| 29/09/2022 08:00 pm | Jefferies Cell and Genetic Medicine Summit |
| 13/09/2022 12:20 am | Morgan Stanley Global Healthcare Conference |
| 20/05/2022 07:30 pm | Annual General Meeting |
| 07/03/2022 05:30 pm | FY 2021 Earnings Release |
| 12/08/2021 04:30 pm | Interim 2021 Earnings Release |
| 04/06/2021 07:00 pm | Jefferies Healthcare Conference |
| 13/05/2021 04:30 pm | Q1 2021 Earnings Release |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,14 | 0,00 0,03 - | 0,00 0,33 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -127 -125 -1.29% | -190 -191 0.52% | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -156 -145 -7.09% | -226 -218 -3.66% | -159 -164 3.24% | -43,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -157 -151 -3.99% | -225 -226 0.13% | -156 -162 3.49% | -42,3 |
|
Net income Million USD | Released Forecast Spread | -37,7 | -157 -150 -4.67% | -223 -224 0.44% | -156 -162 3.49% | -42,3 |
|
EPS USD | Released Forecast Spread | -56,6 | -29,6 -29,7 0.22% | -34,4 -34,3 -0.29% | -24,0 -24,9 3.42% | -6,35 |
| Announcement Date | 26/02/21 | 07/03/22 | 31/03/23 | 21/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,33 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -53,8 -48,8 -10.21% | -54,3 -49,4 -9.81% | -58,7 -54,1 -8.63% | -56,6 -58,5 3.12% | -56,8 -55,3 -2.8% | -33,9 -21,2 -60.1% | -16,6 -23,0 27.95% | -20,4 -16,5 -24.21% | -13,0 -18,4 29.05% | -14,5 | -15,0 | -15,4 | -15,7 | -17,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -54,3 -48,4 -12.12% | -54,6 -49,6 -10.11% | -59,6 -55,2 -7.93% | -56,6 -57,7 1.88% | -54,4 -54,4 -0.16% | -57,1 -20,0 -185.43% | -18,7 -21,4 12.9% | -67,4 -14,3 -370.75% | -12,9 -18,6 30.37% | -14,5 | -15,1 | -15,4 | -15,7 | -17,7 |
|
Net income Million USD | Released Forecast Spread | -55,4 -48,4 -14.31% | -54,6 -49,6 -10.11% | -59,0 -55,2 -6.83% | -56,2 -57,7 2.53% | -53,8 -54,4 0.96% | -57,1 -22,6 -152.6% | -18,7 -21,4 12.9% | -67,4 -14,3 -370.75% | -12,9 -18,6 30.37% | -14,5 | -15,1 | -15,4 | -15,7 | -17,7 |
|
EPS USD | Released Forecast Spread | -9,00 -7,53 -19.47% | -8,40 -7,67 -9.57% | -9,20 -8,40 -9.52% | -8,60 -8,90 3.37% | -8,20 -8,20 0% | -8,80 -6,87 -28.16% | -2,80 -2,95 5.08% | -10,4 -2,00 -420% | -1,99 -2,85 30.05% | -2,23 | -2,30 | -2,34 | -2,31 | -2,35 |
| Announcement Date | 07/03/22 | 16/05/22 | 12/08/22 | 14/11/22 | 31/03/23 | 11/05/23 | 14/08/23 | 13/11/23 | 21/03/24 | - | - | - | - | - |
More events
Past sector events for Instil Bio, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TIL Stock
- Calendar Instil Bio, Inc.
